ORINASE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Orinase, and what generic alternatives are available?
Orinase is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in ORINASE is tolbutamide sodium. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORINASE?
- What are the global sales for ORINASE?
- What is Average Wholesale Price for ORINASE?
Summary for ORINASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 121 |
Clinical Trials: | 3 |
Patent Applications: | 4,228 |
DailyMed Link: | ORINASE at DailyMed |
Recent Clinical Trials for ORINASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Corcept Therapeutics | Phase 1 |
Daiichi Sankyo, Inc. | Phase 1 |
Novartis | Phase 2 |
US Patents and Regulatory Information for ORINASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | ORINASE | tolbutamide | TABLET;ORAL | 010670-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmacia And Upjohn | ORINASE | tolbutamide | TABLET;ORAL | 010670-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmacia And Upjohn | ORINASE DIAGNOSTIC | tolbutamide sodium | INJECTABLE;INJECTION | 012095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |